BLCO · Bausch & Lomb Corp
Market Cap
$6.16B
Shares
357.17M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$16.85
Open$16.76
Day$16.60–17.00
52W close$14.32–18.60
Avg vol 30d389K
Short int3.4M · 1.0% float · 7.9d
Short vol47%
Last earningsJul 29, 2026
DataMay 2022–Sep 2026
Filing10-Q · Jul 29
Up next
Next earnings call
Oct 28, 2026
Est · unconfirmed
· in 5 wks
filed Jul 29, 2026
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
$5.32B
Trailing 12 months
Net income (TTM)
−$171.00M
Trailing 12 months
Revenue growth YoY
+9.1%
Year over year
Operating margin
6.1%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
2.2%
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
−$4.71B
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+1.0%
Year over year · more shares
Price change (1Y)
+9.6%
Trailing year
Short interest
1.0%
Latest settlement · 7.9 days to cover
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Neutral
Momentum
Weak
Sentiment
Neutral
Fundamentals
Poor
Quant / Vol
Moderate
Market backdrop
VIX 14.8 · calm
Equity put/call 0.58
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+1%
above
Price vs 50-day avg
−0%
below
RSI (14)
43
neutral
MACD trend
Negative
52-week position
59%
mid-range
Momentum
relative strength
1-month return
−2%
trailing
6-month return
+10%
trailing
YTD return
−1%
this year
Relative strength
−10%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $17 › 200d $17 — 50d above 200d
Institutional flow
Accumulating
+2% holders QoQ · +19 funds added
Insider flow
Distributing
Net -$1.2M over 90 days · 100% sells
Short interest
Rising
0.95% of float · ▲ +7.1% MoM · 7.9 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
98 holders — mid 3-yr range
Squeeze score
57
elevated · 0–100
Fundamentals
Revenue growth
+6%
Y/Y
EPS growth
−13%
Y/Y
Free cash flow
$-66.0M
Balance sheet
$4.7B
net debt
Quant / Vol
risk profile
Volatility
29%
annualized · 1-yr
Max drawdown
−20%
past year
ATR
2.8%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Latest guidance
· from the 8-K filed Jul 29, 2026
Full-Year constant currency revenue growth
· Full-Year 2026
Non-GAAP
Initiated
5.8% – 7.7%
Full-Year Revenue Foreign Exchange Tailwinds
· Full-Year 2026
Initiated
$45M
Prior guidance
period ended
· from the 8-K filed Jul 31, 2024
Full-year Adjusted EBITDA (non-GAAP)
· full year 2024
$850M – $900M
Guided vs delivered
· last 1 settled
Revenue
Full-year 2024
guided $4.6B – $4.7B
$4.79B
Beat +3.0%
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Neutral
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+1%
Bullish
Price vs 50-day avg
−0%
Neutral
RSI (14)
43
Neutral
MACD trend
Negative
Bearish
52-week position
59%
Neutral
Market signals — smart money & positioning
Bearish · 2 of 6
Trend (MA cross)
No cross
50d $17 › 200d $17 — 50d above 200d
Institutional flow
Accumulating
+2% holders QoQ · +19 funds added
Insider flow
Distributing
Net -$1.2M over 90 days · 100% sells
Short interest
Rising
0.95% of float · ▲ +7.1% MoM · 7.9 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
98 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $14
Now $17 · 59%
Range high $19
vs 200-day avg +1%
vs 50-day avg 0%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
Earlier KPI extraction records exist, but do not meet the current evidence-completeness requirements. No current verified series is available. Earlier figures remain withheld until revalidated; this is not evidence that the company reports no KPIs.
Versus peers
Medical Instruments & Supplies — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
BLCO
this stock
Bausch & Lomb Corp
|
$6.16B | -1.3% | +6.5% | — | 1.0% |
|
ISRG
Intuitive Surgical Inc
|
$137.70B | -30.6% | +20.5% | 44.8 | 2.2% |
|
BDX
Becton Dickinson & Co
|
$50.64B | — | +8.2% | — | 3.9% |
|
MDLN
Medline Inc.
|
$41.60B | -24.7% | +11.5% | — | 3.0% |
|
ALC
Alcon Inc
|
$32.76B | -17.5% | +10.5% | — | 3.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| BLCO | -2.3% | -2.0% | +9.6% | -3.6% | -1.4% |
| SPY | -0.3% | -0.1% | +20.1% | -0.7% | +11.7% |
| vs SPY | -2.0% | -1.9% | -10.5% | -2.9% | -13.1% |